Guy Mullenbach
Chiron Corporation
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Guy Mullenbach.
Nature | 1986
Kang-Sheng Wang; Qui-Lim Choo; Amy J. Weiner; Jing-Hsiung Ou; Richard Najarian; Richard M. Thayer; Guy Mullenbach; Katherine J. Denniston; John L. Gerin; Michael Houghton
Biochemical and electron microscopic data indicate that the human hepatitis δ viral agent contains a covalently closed circular and single-stranded RNA genome that has certain similarities with viroid-like agents from plants. The sequence of the viral genome (1,678 nucleotides) has been determined and an open reading frame within the complementary strand has been shown to encode an antigen that binds specifically to antisera from patients with chronic hepatitis δ viral infections.
Biochemical and Biophysical Research Communications | 1991
Karin C. Imlay; Pandora Lee; Noel M. Fong; Carol Gallegos; Elizabeth D. Getzoff; John A. Tainer; Diane E. Cabelli; Patricia Tekamp-Olson; Guy Mullenbach; Lawrence S. Cousens
Human CuZn superoxide dismutase (HSOD) has two free cysteines: a buried cysteine (Cys6) located in a beta-strand, and a solvent accessible cysteine (Cys111) located in a loop region. The highly homologous bovine enzyme (BSOD) has a single buried Cys6 residue. Cys6 residues in HSOD and BSOD were replaced by alanine and Cys111 residues in HSOD by serine. The mutant enzymes were expressed and purified from yeast and had normal specific activities. The relative resistance of the purified proteins to irreversible inactivation of enzymatic activity by heating at 70 degrees C was HSOD Ala6 Ser111 greater than BSOD Ala6 Ser109 greater than BSOD Cys6 Ser109 (wild type) greater than HSOD Ala6 Cys111 greater than HSOD Cys6 Ser111 greater than HSOD Cys111 (wild type). In all cases, removal of a free cysteine residue increased thermostability.
European Biophysics Journal | 1994
Ivano Bertini; Mario Piccioli; Maria Silvia Viezzoli; Choi Ying Chiu; Guy Mullenbach
A mutated protein of human Cu(II)2Zn(II)2 SOD in which residues Phe50 and Gly51 at the dimer interface were substituted by Glus, thus producing a monomeric species, has been characterized by electronic absorption spectroscopy, EPR, relaxivity and1H NMR techniques. Such substitutions and/or accompanying remodeling and exposure of the dimer interface to solvent, alter the geometry of the active site: increases in the axiality of the copper chromophore and the Cu-OH2 distance have been observed. The affinity of both metal binding sites for Co(II) is also altered. The observed NMR parameters of the Co(II) substituted derivative have been interpreted as a function of the decrease of rotational correlation time as a consequence of the lower molecular weight of the mutated protein. Sharper NMR signals are also obtained for the reduced diamagnetic enzyme. Results are consistent with an active site structure similar to that observed for the dimeric analog Thr137Ile characterized elsewhere. An observed proportional decrease in enzymatic activity and affinity for the N3-anion suggests the importance of electrostatic forces during substrate docking and catalysis.
Cytokine | 1994
Anna Kurdowska; Allen B. Cohen; Ferdicia K. Carr; Michael D. Stevens; Edmund J. Miller; Guy Mullenbach; Patricia Tekamp-Olson
We examined the biological and kinetic characteristics of two new members of the intercrine family of cytokines. Human macrophage inflammatory peptides 2 alpha and beta (huMIP-2 alpha and beta) were compared to human interleukin 8 (huIL-8), neutrophil activating peptide 2 (huNAP-2), and N-formyl-L-methionyl-L-phenylalanine (fMLP). The huMIP-2 peptides were the least potent cytokine tested in triggering neutrophil degranulation. They were also less potent neutrophil chemotaxins than fMLP or huIL-8. However, they were more effective than NAP-2 in stimulating chemotaxis of neutrophils. The binding studies showed that huMIP-2 peptides could interact with specific receptors on human blood neutrophils. Moreover, huMIP-2 peptides competed for up to 60% of the huIL-8 binding sites on neutrophils whereas huIL-8 competed for almost 100% of either of the huMIP-2 peptide binding sites. These data suggest the huMIP-2 peptides have little or no affinity for 40% of the huIL-8 receptors. In addition, detectable amounts of mRNA for huMIP-2 alpha were found in samples from human alveolar macrophages stimulated with Staphylococcus aureus, toxic shock syndrome toxin-1 (TSST), but not in samples stimulated with S. aureus enterotoxin A (SEA) or Escherichia coli endotoxin (lipopolysaccharide = LPS). In conclusion, huMIP-2 alpha and beta are weak neutrophil stimulating agents, which may increase inflammation in diseases such as toxic shock syndrome.
Nature | 1983
Graeme I. Bell; Robert F. Santerre; Guy Mullenbach
Nucleic Acids Research | 1985
F.R. Masiarz; R.C. Najarian; J.P. Purna; M.R. Quiroga; A. Randolph; Ray Sanchez-Pescador; C.J. Scandella; B. Smith; K.S. Steimer; Guy Mullenbach
Journal of Biological Chemistry | 1989
I. Laria; A. Tabrizi; G. Carlin; Elizabeth D. Getzoff; John A. Tainer; Lawrence S. Cousens; Guy Mullenbach
Nucleic Acids Research | 1987
Guy Mullenbach; Azita Tabrizi; Bruce Irvine; Graeme I. Bell
Protein Engineering | 1988
Guy Mullenbach; Azita Tabrizi; Bruce Irvine; Graeme I. Bell; John A. Tainer
Journal of Biological Chemistry | 1992
Jeffrey A. Moscow; Charles S. Morrow; Rui He; Guy Mullenbach; Kenneth H. Cowan